Table 3. Genotype and allele distributions in ApoE genotype groups with ACI patients and controls.

rs2910164 (n)	Genotypes n (%)
ApoEε4(−)	CC	GC	GG	p-value
ACI (94)	59 (62.77%)	28 (29.79%)	7 (7.45%)	0.119
Controls (37)	16 (43.24%)	16 (43.24%)	5 (13.51%)
ApoEε4(−)
ACI (203)	82 (40.39%)	100 (49.26%)	21 (10.34%)	0.733
Controls (263)	97 (36.88%)	136 (51.71%)	30 (11.41%)
Rs57095329 (n)	Genotypes n (%)
ApoEε4(−)	AA	GA	GG	p-value
ACI (94)	66 (70.21%)	27 (28.72%)	1 (1.06%)	0.326
Controls (37)	25 (67.57%)	10 (27.03%)	2 (5.41%)
ApoEε4(−)
ACI (203)	134 (66.01%)	60 (29.56%)	9 (4.43%)	0.222
Controls (263)	186 (70.72%)	72 (27.38%)	5 (1.90%)
rs2910164 (n)	Alleles n (%)
ApoEε4(−)	G	C	p-value	OR (95% CI)
ACI (94)	42 (22.24%)	146 (77.66%)	0.033*	0.531 (0.295–0.956)
Controls (37)	26 (35.14%)	48 (64.87%)
ApoEε4(−)
ACI (203)	142 (34.98%)	264 (65.03%)	0.472	0.906 (0.691–1.186)
Controls (263)	196 (37.26%)	330 (62.74%)
Rs57095329 (n)	Alleles n (%)
ApoEε4(−)	G	A	p-value	OR (95% CI)
ACI (94)	29 (15.43%)	159 (84.57%)	0.492	0.782 (0.387–1.580)
Controls (37)	14 (18.92%)	60 (81.08%)
ApoEε4(−)
ACI (203)	78 (19.21%)	328 (80.79%)	0.146	1.288 (0.915–1.811)
Controls (263)	82 (15.59%)	444 (84.41%)
rs2910164 (n)	Recessive model
ApoEε4(−)	GG−GC .vs. CC	p-value		OR (95% CI)
ACI (94)	35 (37.24%)	0.04*		0.452 (0.209–0.980)
Controls (37)	21 (56.75%)
ApoEε4(−)
ACI (203)	121 (59.61%)	0.440		0.862 (0.5920–1.256)
Controls (263)	166 (63.12%)
Rs57095329 (n)	Recessive model
ApoEε4(−)	GG−GA. vs. AA	p-value		OR (95% CI)
ACI (94)	28 (29.897%)	0.767		0.884 (0.390–2.00)
Controls (37)	12 (32.44%)
ApoEε4(−)
ACI (203)	69 (33.99%)	0.277		1.24 (0.8391–1.844)
Controls (263)	77 (29.28%)

Adjusted for age, sex, hypertension and diabetes.

^*p < 0.05.